New drug trial targets rare blood disorder where body attacks its own red cells
NCT ID NCT05535933
Summary
This clinical trial is testing an investigational drug called HMPL-523 for adults with warm antibody autoimmune hemolytic anemia (wAIHA), a condition where the immune system mistakenly destroys red blood cells. The study aims to see if the drug can safely and effectively increase and sustain hemoglobin levels, a key measure of red blood cell health. It involves about 110 participants and compares the drug against a placebo to determine its benefits.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Binzhou Medical College
Binzhou, Shandong, China
-
Affiliated Hospital of Guangdong Medical University
Zhanjiang, Guangdong, China
-
Affiliated hospital of Hebei university
Baoding, Hebei, China
-
Affiliated hospital of chengde medical university
Chengde, Hebei, China
-
Affiliated hospital of nantong university
Nantong, Jiangsu, China
-
Bethune First Hospital Of Jilin University
Changchun, Jilin, China
-
Chenzhou First People's Hospital
Chenzhou, Hunan, China
-
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
-
Fuyang Hospital Of Anhui Medical University
Fuyang, Anhui, China
-
Guilin Medical College Affiliated Hospital
Guilin, Guangxi, China
-
Hainan General Hospital
Haikou, Hainan, China
-
Harbin First Hospital
Harbin, Heilongjiang, China
-
Hematology Hospital of Chinese Academy of Medical Sciences
Tianjin, China
-
Henan Cancer Hospital
Zhengzhou, Henan, China
-
Heping Hospital Affiliated To Changzhi Medical College
Changzhi, Shanxi, China
-
Jiangsu province hospital
Nanjing, Jiangsu, China
-
Jiangxi Provincial people's Hospital
Nanchang, Jiangxi, China
-
Jinshan Hospital of Fudan University
Shanghai, Shanghai Municipality, China
-
Lanzhou University Second Hospital
Lanzhou, Gansu, China
-
Nanfang hospital
Guangzhou, Guangdong, China
-
Peking Union Medical College Hospital
Beijing, China
-
Qinghai provincial people's hospital
Xining, Qinghai Provincial, China
-
Shaanxi Provincial People's Hospital
Xi'an, Shaanxi, China
-
Shenzhen Second People's Hospital
Shenzhen, Guangdong, China
-
The Affiliated Hospital of Southwest Medical University
Luzhou, Sichuan, China
-
The First Affiliated Hospital of Henan University Of Science and Technology
Luoyang, Henan, China
-
The First Affiliated Hospital of WMU
Wenzhou, Zhejiang, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
The First People's Hospital of Changde City
Changde, Hunan, China
-
The First affiliated hospital of nanchang uiversity
Nanchang, Jiangxi, China
-
The Second Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
-
The third xiangya hospital of central south university
Changsha, Hunan, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
-
Xiangya Hospital of Central South University
Changsha, Hunan, China
-
Xiangyang Center Hospital
Xiangyang, Hubei, China
-
Xinjiang Uygur Autonomous Region People's Hospital
Ürümqi, Xinjiang, China
-
Xinxiang Central Hospital
Xinxiang, Henan, China
-
Yantai Yuhuangding Hospital
Yantai, Shandong, China
Conditions
Explore the condition pages connected to this study.